In its quest to further promote vaccination as an efficient tool to prevent infections from undermining public health, Olpharm Nigeria Limited, a foremost pharmaceutical company, in partnership with Biological E Limited, the first Indian private company to enter into the Nigerian vaccine field, has unveiled a range of vaccines into the Nigerian pharma market.
The unveiled products included ComBE Five, Liquid (DTwP – rHepB – Hib); BEtt, Adsorbed Tetanus Vaccine BP; BEVAC Hepatitis B Vaccine (rDNA)BP, for adult; BE Td, Diphtheria and Tetanus Vaccine (Adsorbed) for adult and adolescents, and BEVAC Hepatitis B Vaccine (rDNA) BP for children.
The colourful ceremony, which took place at The Providence Hotel, Ikeja GRA, Lagos, on 7 February, 2020, had eminent pharmacists, nurses, doctors and other dignitaries in attendance.
In his welcome remark at the event, Pharm. Johnson Olusetire, managing director/CEO, Olpharm Nigeria Limited, explained that vaccination against preventable diseases has been identified as one of the most cost-effective interventions in saving lives, adding that vaccination remains the best form of defence against diseases.
Olusetire disclosed that the company was glad and proud to partner with Biological E, which he said was one of the companies with the World Health Organistaion (WHO), prequalified vaccines in the world, as well as being a reputable company that is globally acclaimed for quality vaccines.
The Olpharm also stated that the company’s decision to partner with Biological E in launching the new products, was born out of the need to go into preventive medicines, as against the former focus on curative care, adding that it had been discovered that there was a wide gap between curative medicines and vaccination in Nigeria, and that the company had come to fill that gap.
“We want everybody, both adults and children, to imbibe the culture of vaccination because vaccines save lives ahead of danger. This is one the advantages the developed countries have over the underdeveloped countries. We aim to get the vaccines to the individuals, families, communities and the society at large,” he said.
Also speaking at the event, the General Manager, International Marketing, Biological E Limited, Dulam Pramodh, said the company is committed to supplying vaccines that meet the highest International standards to fight all vaccine-preventable diseases afflicting mankind, adding that the company’s vast product range encompasses the whole spectrum of pharmaceuticals, from preventive to therapeutic, with a reputation for quality, safety and efficacy.
Speaking further, Pramodh, who is a pharmacist, noted that Olpharm and Biological E have similar ideologies and are both concerned about the wide gap between vaccination and medication in Nigeria; hence the need for the partnership and the launch of the first batch of the vaccines.
While expressing optimism about the partnership, Pramodh said he was delighted to be working with Olpharm, an established and reputable company in the Nigerian pharmaceutical market. He stressed that the partnership was fully aligned with Biological E’s vision of providing high quality vaccines to the private and public sector, adding that by leveraging Olpharm’s strengths in Nigeria market, the partnership is bound to succeed.
While also speaking at the event, Dr Emuobor Odeghe, a consultant physician and gastroenterologist, Lagos University Teaching Hospital (LUTH), noted that vaccines had greatly reduced the prevalence of diseases everywhere in the world, saying the world can make more progress against early death and disease with the help of vaccines.
Other notable guests at the event included, Sandeep Dhyani, senior manager, International Marketing, Biological E Limited; Dr Anifowoshe Aderinsola, Community Health dep, LASUTH; Mrs. Fadeke Adeyemi, Vacipharm Limited; Dr Uchenna Owowo, paediatric, Lifeline Clinic; Dr Elizabeth Onifade, managing director, Lifeline Clinic; Pharm. Ojo Oluseyi, Victory Drugs; Dr Sonoiki Olushola, community health, LASUTH; Pharm. Rotimi Oyewusi, Pharmaton; Dr C U Nwoku, gastroenterologist, LUTH; Mrs Lois Mosebolatan, Nursing, LASUTH and Mr Adekola Wojuola, and managing director, Honeyvent Pharma Nigeria Limited.